Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer. - Wikidata - awgldk - TriplyDB

Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.

Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.

http://www.wikidata.org/entity/Q42145392

about

Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.Lactoferrin from Camelus dromedarius Inhibits Nuclear Transcription Factor-kappa B Activation, Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Stimulated Human Chondrocytes.Potential role of garcinol as an anticancer agent.Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.

P2860

Q26798203-FCACA06E-0C65-4463-A301-713E36BB9767 Q34586675-7320B081-44CA-4058-883A-C2B7B04EFBA2 Q35791583-FDE4CDC3-91BD-4EA8-B416-DBB8E191F2E7 Q36084097-26F339B6-0896-47AA-BCF4-0A8384717E66 Q36883777-224FD0EB-8B48-4532-A73F-56CEAB3B33A4 Q38715482-EAF7055B-2739-4885-8516-662FDA375927 Q38760434-2932FE18-F34F-447D-BF64-B00944C14176 Q38806224-4FEEA89E-B64D-49AB-837D-621247692620 Q39417000-052DDFF7-CDCC-4AFD-B708-AC3D76AB0260 Q41592725-6FF5DFF3-48AA-45DC-A19E-5CA1D2CBB266 Q42199704-13C0F964-DD14-488C-9BAC-39D2E3EE7569 Q47133718-82873624-1ABF-44C9-AEAA-9DEFE2567D17

P2860

Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.

http://www.wikidata.org/entity/Q42145392

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Involvement of COX-2/PGE

@nl

Involvement of COX-2/PGE(2) Pa ...... pression in Pancreatic Cancer.

@en

type

label

Involvement of COX-2/PGE

@nl

Involvement of COX-2/PGE(2) Pa ...... pression in Pancreatic Cancer.

@en

prefLabel

Involvement of COX-2/PGE

@nl

Involvement of COX-2/PGE(2) Pa ...... pression in Pancreatic Cancer.

@en

P1433

Q42145392-CB548BD5-7898-4661-8BBD-9FFE65CACD44

P1476

Q42145392-48133E51-F0FD-4408-9882-9CF7A9F882C6

P2093

Q42145392-1CD631E3-E405-40E8-B641-EA4253CEAA6A

Q42145392-49FF2D82-2143-4547-8781-FC7EC7848885

Q42145392-A18A8816-9009-491A-B2D1-B92F03746BD9

P2860

Q42145392-009F4BDB-C736-4691-8BA2-FA297ECFE55D

Q42145392-042B0B19-CAA8-4EB1-A1D5-649CAC88F171

Q42145392-04353561-6ECA-42EC-BFC6-D8855A157228

Q42145392-0994407C-CAC9-432D-983B-C51614A8B4BE

Q42145392-0DFAA10B-2698-4D01-B8F8-AEFC6F8D2F81

Q42145392-230576CA-A119-4E95-ACE1-001C4858C1EA

Q42145392-25BCDC1D-B5F4-4B51-91B2-8AA53A1B4D1B

Q42145392-418D5A3F-55A5-4135-B31C-B42EB992A30F

Q42145392-4A1944A1-5092-415D-82F8-7A45DC862717

Q42145392-4EB21EE0-5637-41BD-A6FE-DAB51661E571

P304

Q42145392-269EBBE1-0DCD-411D-A840-B0284E048025

P31

Q42145392-73D96737-431E-47C5-9690-6E10D7E3C1C4

P356

Q42145392-1932BC73-0D4B-4150-89EF-66D736E5D4EE

P478

Q42145392-1416419F-3AF6-49B3-83B1-2B65F86DC19F

P577

Q42145392-526EB265-7FA6-4473-AE06-AD549915393A

P5875

Q42145392-79CBF92D-618B-49DD-B062-6DC87519EB96

P698

Q42145392-20845412-8467-451B-899E-7CEA1B0EF5DF

P932

Q42145392-ADA93956-9C67-4C68-B3AA-E834C427423E

P356

P1433

Gastroenterology research and practice

P1476

Involvement of COX-2/PGE(2) Pa ...... pression in Pancreatic Cancer.

@en

P2093

Chenghai Zhao

http://www.w3.org/2001/XMLSchema#string

Xianmin Bu

http://www.w3.org/2001/XMLSchema#string

Xianwei Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

Differential expression of cyclooxygenase 2 in human colorectal cancer.

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.

Prostaglandin E(2) stimulates progression-related gene expression in early colorectal adenoma cells.

Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

P304

214269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/214269

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51494121

http://www.w3.org/2001/XMLSchema#string

P698

21760774

http://www.w3.org/2001/XMLSchema#string

P932

3132487

http://www.w3.org/2001/XMLSchema#string